Synthesis of the equine estrogen metabolites 2-hydroxyequilin and 2- hydroxyequilenin

Chemical Research in Toxicology

Volumn 12, Issue 2, 1999, Pages 200-203

  Zhang, Fagen ^a   Bolton, Judy L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYEQUILENIN; 2 HYDROXYEQUILIN; CONJUGATED ESTROGEN; ESTROGEN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DEMETHYLATION; DRUG STRUCTURE; DRUG SYNTHESIS; ESTROGEN SYNTHESIS; REACTION ANALYSIS; STEROL ANALYSIS;

ANIMALS; EQUILENIN; EQUILIN; ESTRADIOL CONGENERS; HORSES; MAGNETIC RESONANCE SPECTROSCOPY;

EQUIDAE;

EID: 0032973128     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx980189g     Document Type: Article

References (29)

1. Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., Hennekens, C. H., and Speizer, F. E. (1997) Postmenopausal hormone therapy and mortality. N. Engl. J. Med. 336, 1769-1775.
2. Wickelgren, I. (1997) Estrogen: A new weapon against Alzheimer's. Science 276, 676-677.
3. Henderson, V. W. (1997) The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 48, S27-S35.
4. Haskell, S. G., Richardson, E. D., and Horwitz, R. I. (1997) The effect of estrogen replacement therapy on cognitive function in women: A critical review of the literature. J. Clin. Epidemiol. 50, 1249-1264.
5. Paganinihill, A. (1995) Estrogen replacement therapy and stroke. Prog. Cardiovasc. Dis. 38, 223-242.
6. Steinberg, K. K., Smith, S. J., Thacker, S. B., and Stroup, D. F. (1994) Breast cancer risk and duration of estrogen use: The role of study design in meta-analysis. Epidemiology 5, 415-421.
7. Davidson, N. E. (1995) Hormone-Replacement Therapy: Breast Versus Heart Versus Bone. N. Engl. J. Med. 332, 1638-1639.
8. Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., and Speizer, F. E. (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 332, 1589-1593.
9. Lupulescu, A. (1995) Estrogen Use and Cancer Incidence. A Review. Cancer Invest. 13, 287-295.
10. Zumoff, B. (1998) Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy. Proc. Soc. Exp. Biol. Med. 217, 30-37.
11. Service, R. F. (1998) New role for estrogen in cancer? Science 279, 1631-1633.
12. Yager, J. D., and Liehr, J. G. (1996) Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36, 203-232.
13. Zhu, B. T., and Conney, A. H. (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19, 1-27.
14. Bolton, J. L., Pisha, E., Zhang, F., and Qiu, S. (1998) Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol. 11, 1113-1127.
15. Shen, L., Qiu, S., van Breemen, R. B., Zhang, F., Chen, Y., and Bolton, J. L. (1997) Reaction of the Premarin metabolite 4-hydroxyequilenin semiquinone radical with 2′-deoxyguanosine: Formation of unusual cyclic adducts. J. Am. Chem. Soc. 119, 11126-11127.
16. Shen, L., Qiu, S., Chen, Y., Zhang, F., van Breemen, R. B., Nikolic, D., and Bolton, J. L. (1998) Alkylation of 2′-deoxynucleosides and DNA by the Premarin metabolite 4-hydroxyequilenin semiquinone radical. Chem. Res. Toxicol. 11, 94-101.
17. Purdy, R. H., Moore, P. H., Williams, M. C., Goldzheher, H. W., and Paul, S. M. (1982) Relative rates of 2-and 4-hydroxyestrogen synthesis are dependent on both substrate and tissue. FEBS Lett. 138, 40-44.
18. Li, S. A., Klicka, J. K., and Li, J. J. (1985) Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. Cancer Res. 45, 181-185.
19. Sarabia, S. F., Zhu, B. T., Kurosawa, T., Tohma, M., and Liehr, J. G. (1997) Mechanism of cytochrome P450-catalyzed aromatic hydroxylation of estrogens. Chem. Res. Toxicol. 10, 767-771.
20. Ikegawa, S., Kurosawa, T., and Tohma, M. (1988) Synthesis of C-2 catecholic equilin and equilenin derivatives for use in metabolic studies. Chem. Pharm. Bull. 36, 2993-2999.
21. Rao, P. N., and Somawardhana, C. W. (1987) Synthesis of 2-methoxy and 4-methoxy equine estrogens. Steroids 49, 419-432.
22. National Institutes of Health (1981) NIH Guidelines for the Laboratory Use of Chemical Carcinogens. NIH Publication No. 81-2385, U.S. Government Printing Office, Washington, DC.
23. Chang, M., Zhang, F., Shen, L., Pauss, N., Alam, I., van Breemen, R. B., Blond-Elguindi, S., and Bolton, J. L. (1998) Inhibition of glutathione S-transferase activity by the quinoid metabolites of equine estrogens. Chem. Res. Toxicol. 11, 758-765.
24. Bachmann, W. E., and Dreiding, A. S. (1950) Epimerization, dehydrogenation, and ring cleavage of some steroids and related compounds by palladium. Stereochemistry of the estrogens. J. Am. Chem. Soc. 72, 1323-1329.
25. 6-dehydroestrone and equilenin. J. Am. Chem. Soc. 72, 4531-4534.
26. Stein, R. P., Buzby, G. C., and Smith, H. (1970) Totally synthetic steroid hormones. XX. Novel total synthesis of equilin and equilenin. Tetrahedron 26, 1917-1933.
27. Hylarides, M. D., Wilbur, D. S., and Mettler, F. A. (1983) B-ring aromatization of estrogen derivatives. Steroids 41, 657-662.
28. Cao, Z., and Liehr, J. G. (1997) An effective approach to B-ring aromatization of equilin. Synth. Commun. 27, 145-155.
29. Shen, L., Pisha, E., Huang, Z., Pezzuto, J. M., Krol, E., Alam, Z., van Breemen, R. B., and Bolton, J. L. (1997) Bioreductive activation of catechol estrogen-ortho-quinones: Aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis 18, 1093-1101.